Ramakrishnan (Ram) Sundaram serves as India Regional Director of Regulatory Affairs, Established Pharmaceuticals Division, for Abbott. He previously served as Director of Regulatory Affairs for both Bristol-Myers Squibb India and Dr. Reddy’s Labs. Mr. Sundaram also served in various roles in regulatory affairs and biologics process development in the US for such companies as Bristol Myers Squibb, ImClone Systems (Eli Lilly), and Millennium Pharmaceuticals (Takeda Oncology), before moving to India for his assignment with Dr. Reddy’s. He received his undergraduate and post-graduate education in the US and in India, and earned his Quality Assurance/Regulatory Affairs certificate from Temple University.